These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38160837)

  • 1. ViCEKb: Vitiligo-linked Chemical Exposome Knowledgebase.
    Chivukula N; Ramesh K; Subbaroyan A; Sahoo AK; Dhanakoti GB; Ravichandran J; Samal A
    Sci Total Environ; 2024 Feb; 913():169711. PubMed ID: 38160837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NeurotoxKb 1.0: Compilation, curation and exploration of a knowledgebase of environmental neurotoxicants specific to mammals.
    Ravichandran J; Karthikeyan BS; Singla P; Aparna SR; Samal A
    Chemosphere; 2021 Sep; 278():130387. PubMed ID: 33838427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network biology approach to human tissue-specific chemical exposome.
    Ravichandran J; Karthikeyan BS; Aparna SR; Samal A
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105998. PubMed ID: 34534667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical leukoderma: An insight of pathophysiology and contributing factors.
    Jangra S; Gulia H; Singh J; Dang AS; Giri SK; Singh G; Priya K; Kumar A
    Toxicol Ind Health; 2024 Aug; 40(8):479-495. PubMed ID: 38814634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway.
    Kaushik H; Kaul D; Kumaran MS; Parsad D
    J Dermatol Sci; 2020 Nov; 100(2):92-98. PubMed ID: 33039241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atlas of fragrance chemicals in children's products.
    Ravichandran J; Karthikeyan BS; Jost J; Samal A
    Sci Total Environ; 2022 Apr; 818():151682. PubMed ID: 34793786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genetic Basis of Vitiligo.
    Spritz RA; Santorico SA
    J Invest Dermatol; 2021 Feb; 141(2):265-273. PubMed ID: 32778407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.
    Dey-Rao R; Sinha AA
    BMC Genomics; 2017 Jan; 18(1):109. PubMed ID: 28129744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-Based Chemical Ranking and Generating a Prioritized Human Exposome Database.
    Zhao F; Li L; Chen Y; Huang Y; Keerthisinghe TP; Chow A; Dong T; Jia S; Xing S; Warth B; Huan T; Fang M
    Environ Health Perspect; 2021 Apr; 129(4):47014. PubMed ID: 33929905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo in Croatia: a case report.
    Bulat V; Situm M; Madiraca D; Majcen K; Dzapo A; Jezovita J
    Coll Antropol; 2014 Dec; 38(4):1191-4. PubMed ID: 25842755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An annotation database for chemicals of emerging concern in exposome research.
    Meijer J; Lamoree M; Hamers T; Antignac JP; Hutinet S; Debrauwer L; Covaci A; Huber C; Krauss M; Walker DI; Schymanski EL; Vermeulen R; Vlaanderen J
    Environ Int; 2021 Jul; 152():106511. PubMed ID: 33773387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic architecture of vitiligo.
    Roberts GHL; Santorico SA; Spritz RA
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):8-15. PubMed ID: 31743585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.